Quick Takeaways
- Duncan McHale has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $5,605.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Duncan McHale
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Duncan McHale is at least $5,605 dollars as of 08 Nov 2023. Duncan McHale is the Chief Medical Officer of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. (EVLO) stock worth about $5.6K.
- Signature
- /s/ Marella Thorell, Attorney-in-Fact for Duncan McHale
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Duncan McHale and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Evelo Biosciences, Inc. ($5,605).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Duncan McHale
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | Chief Medical Officer | $5,605 | 07 Nov 2023 |
Insider Transactions Reported by Duncan McHale:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.